Orange Book product · Generic (ANDA)
METHAZOLAMIDE
METHAZOLAMIDE
At a glance
Feb 09, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 09, 2026
4 mo ago
Today
Pharmaceutical detail
Active ingredient
METHAZOLAMIDE
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 217408
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of METHAZOLAMIDE
- 1991NEPTAZANEBrand (NDA)
NDA 011721 · LEDERLE
- 2022METHAZOLAMIDEGeneric (ANDA)
ANDA 215615 · TAGI
- 2018METHAZOLAMIDEGeneric (ANDA)
ANDA 207438 · BAUSCH AND LOMB INC
- 1997METHAZOLAMIDEGeneric (ANDA)
ANDA 040011 · APPLIED ANAL
- 1996METHAZOLAMIDEGeneric (ANDA)
ANDA 040102 · POM PHARMA
- 1994METHAZOLAMIDEGeneric (ANDA)
ANDA 040062 · ANDA REPOSITORY
- 1993METHAZOLAMIDEGeneric (ANDA)
ANDA 040001 · ANI PHARMS
- 1993METHAZOLAMIDEGeneric (ANDA)
ANDA 040036 · CHARTWELL RX
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
